Tenet Healthcare Corporation
NYSE•THC
CEO: Dr. Saumya Sutaria M.D.
Sector: Healthcare
Industry: Medical - Care Facilities
Listing Date: 1980-03-17
Tenet Healthcare Corporation operates as a diversified healthcare services company in the United States. The company operates through two segments: Hospital Operations and Services, and Ambulatory Care. Its general hospitals offer acute care services, operating and recovery rooms, radiology and respiratory therapy services, clinical laboratories, and pharmacies. The company also provides intensive and critical care, and/or coronary care units; cardiovascular, digestive disease, neurosciences, musculoskeletal, and obstetrics services; outpatient services, including physical therapy; tertiary care services, such as cardiothoracic surgery, complex spinal surgery, neonatal intensive care, and neurosurgery services; quaternary care services in heart and kidney transplants; and limb salvaging vascular procedure, acute level 1 trauma, intravascular stroke care, minimally invasive cardiac valve replacement, imaging, surgical robotic, and telemedicine access services. In addition, it offers a range of procedures and services, such as orthopedics, total joint replacement, and spinal and other musculoskeletal procedures; gastroenterology; pain management; otolaryngology; ophthalmology; and urology. It operates hospitals, ambulatory surgery centers, imaging centers, surgical hospitals, off-campus emergency departments, and micro-hospitals. Tenet Healthcare Corporation was founded in 1967 and is headquartered in Dallas, Texas.
Contact Information
Market Cap
$16.76B
P/E (TTM)
12.0
15
Dividend Yield
--
52W High
$247.21
52W Low
$109.82
52W Range
Rank58Top 85.6%
2.3
F-Score
Modified Piotroski Analysis
Based on 10-year fundamentals
Weak • 2.3 / 9 points
Scoring Range (0-9)
8-9: Excellent Value
6-7: Strong Fundamentals
4-5: Average Quality
0-3: Weak Performance
Data Period: 2016-2025
Financial Dashboard
Q4 2025 Data
Revenue
$5.53B+0.00%
4-Quarter Trend
EPS
$4.25+0.00%
4-Quarter Trend
FCF
$367.00M+0.00%
4-Quarter Trend
2025 Annual Earnings Highlights
Key Highlights
Ambulatory Care Revenue Surges Ambulatory Care net operating revenues increased $638M, or 14.1%, driven by acquisitions and same-facility growth.
Hospital Revenue Growth Steady Hospital Operations same-hospital net revenues grew $973M, or 6.5%, due to favorable payer mix and acuity.
Consolidated Operating Income Drops Consolidated operating income fell $2.448B to $3.508B, impacted by asset sales/impairment charges recorded.
Conifer Ownership Fully Secured Strategic transaction finalized January 2026, returning full ownership of Conifer Health Solutions to Tenet.
Risk Factors
Managed Care Revenue Concentration Top 10 managed care payers generated 69% of Hospital Operations segment net patient service revenues in 2025.
Healthcare Policy Regulatory Uncertainty OBBBA implementation creates uncertainty regarding future Medicaid payments and potential coverage losses starting 2027.
Labor Costs Face Inflation Pressure Competition for qualified staff drives up wages and benefits, impacting operating expenses across segments.
Elevated Cybersecurity Threat Risk Risk of cyber-attack remains elevated following 2022 incident; requires significant ongoing resource investment.
Outlook
Focus on Ambulatory Care Expansion Continue expanding Ambulatory Care segment via acquisitions, organic growth, and new outpatient center construction.
Improve Profitability Through Efficiency Focus on growing patient volumes, cost management, and utilizing contracting strategies to enhance profitability.
AI Adoption for Care Enhancement Accelerate adoption of AI and Generative AI tools to enhance clinical coordination and administrative services efficiency.
Capital Structure Management Ongoing Executed new 2025 Credit Agreement; staggered debt maturities minimize near-term interest rate impact.
Peer Comparison
Revenue (TTM)
$75.60B
$21.31B
$17.36B
Gross Margin (Latest Quarter)
90.6%
41.9%
41.5%
Key Metrics
Symbol | Market Cap | P/E (TTM) | ROE (TTM) | Debt to Assets |
|---|---|---|---|---|
| HCA | $106.92B | 16.3 | -140.8% | 82.7% |
| THC | $16.76B | 12.0 | 34.8% | 44.4% |
| ENSG | $11.48B | 33.1 | 16.6% | 76.1% |
Long-Term Trends
Last 4 Quarters
Revenue
Net Income
Operating Cash Flow
4Q Revenue CAGR
1.9%
Moderate Growth
4Q Net Income CAGR
-3.0%
Stable Profitability
Cash Flow Stability
100%
Strong Cash Flow
Deep Research
Next earnings:Apr 27, 2026
EPS:-
|Revenue:-
Financials
Earnings Calls
Reports
News
Income Statement
Balance Sheet
Cash Flow Statement
Ratios
% Chg.
Income Statement | LTM |
|---|
No Data